These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35462858)

  • 1. Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis.
    van de Wiel SMW; Porteiro B; Belt SC; Vogels EWM; Bolt I; Vermeulen JLM; de Waart DR; Verheij J; Muncan V; Oude Elferink RPJ; van de Graaf SFJ
    JHEP Rep; 2022 May; 4(5):100463. PubMed ID: 35462858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter.
    Dawson PA; Hubbert M; Haywood J; Craddock AL; Zerangue N; Christian WV; Ballatori N
    J Biol Chem; 2005 Feb; 280(8):6960-8. PubMed ID: 15563450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic Solute Transporter α-β Protects Ileal Enterocytes From Bile Acid-Induced Injury.
    Ferrebee CB; Li J; Haywood J; Pachura K; Robinson BS; Hinrichs BH; Jones RM; Rao A; Dawson PA
    Cell Mol Gastroenterol Hepatol; 2018; 5(4):499-522. PubMed ID: 29930976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
    Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Farnesoid X Receptor Activation by Pharmacologic Inhibition of the Organic Solute Transporter α-β.
    van de Wiel SMW; de Waart DR; Oude Elferink RPJ; van de Graaf SFJ
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):223-237. PubMed ID: 29675448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.
    Soroka CJ; Mennone A; Hagey LR; Ballatori N; Boyer JL
    Hepatology; 2010 Jan; 51(1):181-90. PubMed ID: 19902485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis.
    Rao A; Haywood J; Craddock AL; Belinsky MG; Kruh GD; Dawson PA
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3891-6. PubMed ID: 18292224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
    Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism.
    Lan T; Rao A; Haywood J; Kock ND; Dawson PA
    J Hepatol; 2012 Aug; 57(2):359-65. PubMed ID: 22542490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic solute transporter, OSTalpha-OSTbeta: its role in bile acid transport and cholestasis.
    Soroka CJ; Ballatori N; Boyer JL
    Semin Liver Dis; 2010 May; 30(2):178-85. PubMed ID: 20422499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids.
    Frankenberg T; Rao A; Chen F; Haywood J; Shneider BL; Dawson PA
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G912-22. PubMed ID: 16357058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia.
    Ballatori N; Christian WV; Lee JY; Dawson PA; Soroka CJ; Boyer JL; Madejczyk MS; Li N
    Hepatology; 2005 Dec; 42(6):1270-9. PubMed ID: 16317684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice.
    Kunst RF; de Waart DR; Wolters F; Duijst S; Vogels EW; Bolt I; Verheij J; Beuers U; Oude Elferink RPJ; van de Graaf SFJ
    JHEP Rep; 2022 Nov; 4(11):100573. PubMed ID: 36160754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of altered bile acid homeostasis in organic solute transporter-alpha knockout mice.
    Lan T; Haywood J; Rao A; Dawson PA
    Dig Dis; 2011; 29(1):18-22. PubMed ID: 21691100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic solute transporter-β (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis.
    Sultan M; Rao A; Elpeleg O; Vaz FM; Abu-Libdeh B; Karpen SJ; Dawson PA
    Hepatology; 2018 Aug; 68(2):590-598. PubMed ID: 28898457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver.
    Ballatori N; Fang F; Christian WV; Li N; Hammond CL
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G179-G186. PubMed ID: 18497332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic functions of the organic solute transporter Ostα-Ostβ.
    Ballatori N
    Dig Dis; 2011; 29(1):13-7. PubMed ID: 21691099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced ileal expression of OSTalpha-OSTbeta in non-obese gallstone disease.
    Renner O; Harsch S; Strohmeyer A; Schimmel S; Stange EF
    J Lipid Res; 2008 Sep; 49(9):2045-54. PubMed ID: 18469300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice.
    Kunst RF; Bolt I; van Dasselaar RDJ; Nijmeijer BA; Beuers U; Oude Elferink RPJ; van de Graaf SFJ
    JHEP Rep; 2024 Jan; 6(1):100917. PubMed ID: 38074508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes.
    Schaffner CA; Mwinyi J; Gai Z; Thasler WE; Eloranta JJ; Kullak-Ublick GA
    Liver Int; 2015 Apr; 35(4):1152-61. PubMed ID: 24703425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.